Routinely offer MenB jabs to prevent gonorrhoea, UK vaccine … – The BMJ

The Joint Committee on Vaccination and Immunisation (JCVI) has advised the UK government that meningococcal B (MenB) vaccines should be routinely offered to prevent gonorrhoea by targeting the people at greatest risk.1

Evidence indicates that, even with a modest vaccine effectiveness against gonorrhoea of 32.7-42.0%, rolling out the 4CMenB vaccine to groups with the highest risk could prevent many cases, said the committee. Because infection with the Neisseria gonorrhoeae bacterium does not protect against future infection, many people are commonly reinfected.

Andrew Pollard, JCVI chair, said that

Read the rest here:

Routinely offer MenB jabs to prevent gonorrhoea, UK vaccine ... - The BMJ